Add to Favorites Newsroom RSS Share
San Francisco, CA USA

Our News on Newswise

Glaucoma Research Foundation to Honor Leaders in Glaucoma Innovation and Patient Care at 12th Annual Gala in San Francisco

The Catalyst Award, Glaucoma Research Foundation's highest honor, will be presented to Thomas W. Burns, President and CEO of Glaukos Corporation (Laguna Hills, CA), in recognition of his remarkable leadership and commitment to the development of...
26-Jan-2018 2:05 PM EST Add to Favorites

Glaucoma Research Foundation to Host the 7th Annual Glaucoma 360

Glaucoma Research Foundation will host the 7th Annual Glaucoma 360 from February 8th to February 10th in San Francisco. This signature three-day event highlights innovation in glaucoma to ensure patients have access to the latest and most effective...
26-Jan-2018 2:05 PM EST Add to Favorites

Biomarkers and Drug Discovery: Jeffrey L. Goldberg, MD, PhD

Dr. Jeff Goldberg: I really want to thank the Glaucoma Research Foundation. Obviously, what we’re going to talk about today would not come to fruition without the support of the Glaucoma Research Foundation and of course, all of their supporters.
13-Dec-2017 2:05 PM EST Add to Favorites

How Sleep Apnea May Contribute to Normal-Tension Glaucoma Risk

People with obstructive sleep apnea syndrome (OSAS), a disorder characterized by repetitive episodes of paused and shallow breathing during sleep, are approximately ten times more likely to develop glaucoma.
22-Aug-2017 3:05 PM EDT Add to Favorites

Glaucoma Research Foundation Now Accepting Preliminary Proposals for 2018 Research Grants

Research scientists interested in applying for a 1-year, $40,000 Shaffer Grant should visit the Glaucoma Research Foundation website.
8-Jun-2017 2:45 PM EDT Add to Favorites

Making Glaucoma Treatment Even Easier With Sustained Release Medication

Traditional eye drops, while the go-to medication option for glaucoma patients, still have lots of room for improvement. Dosing regimens can be difficult to manage or remember, irritation or redness can occur, and much of the medication gets blinked...
30-May-2017 1:50 PM EDT Add to Favorites

4Star125x125.jpg

Glaucoma Research Foundation Earns Highest 4-Star Rating From Charity Navigator

The 4-star rating is Charity Navigator’s highest rating, indicating that “Glaucoma Research Foundation exceeds industry standards and outperforms most charities in its Cause.”
3-May-2017 2:05 PM EDT Add to Favorites

John-Flanagan_800x800.jpg

John G. Flanagan, PhD, FCOptom, Dean of the UC Berkeley School of Optometry, joins Glaucoma Research Foundation Board of Directors

Glaucoma Research Foundation, the nation’s most experienced foundation dedicated solely to glaucoma research and education, recently elected John G. Flanagan, PhD, FCOptom to its Board of Directors.
1-May-2017 3:05 PM EDT Add to Favorites


see all news

Our Experts on Newswise

jeff-goldberg-lab-coat_290.jpg

At present, the only FDA approved method of treating glaucoma is to lower eye pressure; this slows the progression of glaucomatous optic nerve damage but does not completely halt it, and certainly does not regenerate damaged nerve tissue.
16-Jun-2017 11:45 AM EDT

Stem cells may have the potential to protect the optic nerve from further damage and slow the progression of vision loss due to glaucoma. Stem cells may also have the potential to replace ocular tissues that have degenerated in eyes with glaucoma.
17-Mar-2016 9:05 AM EDT

see all experts

Our YouTube Videos





Chat now!